BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 10872884)

  • 21. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription.
    Muir A; Peck A; Clare-Salzler M; Song YH; Cornelius J; Luchetta R; Krischer J; Maclaren N
    J Clin Invest; 1995 Feb; 95(2):628-34. PubMed ID: 7860747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Th1 and Th2 pancreatic inflammation differentially affects homing of islet-reactive CD4 cells in nonobese diabetic mice.
    Hill NJ; Van Gunst K; Sarvetnick N
    J Immunol; 2003 Feb; 170(4):1649-58. PubMed ID: 12574327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice.
    Kay TW; Parker JL; Stephens LA; Thomas HE; Allison J
    J Immunol; 1996 Oct; 157(8):3688-93. PubMed ID: 8871671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-A2-matched peripheral blood mononuclear cells from type 1 diabetic patients, but not nondiabetic donors, transfer insulitis to NOD-scid/γc(null)/HLA-A2 transgenic mice concurrent with the expansion of islet-specific CD8+ T cells.
    Whitfield-Larry F; Young EF; Talmage G; Fudge E; Azam A; Patel S; Largay J; Byrd W; Buse J; Calikoglu AS; Shultz LD; Frelinger JA
    Diabetes; 2011 Jun; 60(6):1726-33. PubMed ID: 21521873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4.
    Rothe H; Faust A; Schade U; Kleemann R; Bosse G; Hibino T; Martin S; Kolb H
    Diabetologia; 1994 Nov; 37(11):1154-8. PubMed ID: 7532600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
    Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
    Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
    Christianson SW; Shultz LD; Leiter EH
    Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
    Lejon K; Fathman CG
    J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathological changes in insulin, glucagon and somatostatin cells in the islets of NOD mice during cyclophosphamide-accelerated diabetes: a combined immunohistochemical and histochemical study.
    Reddy S; Pathipati P; Bai Y; Robinson E; Ross JM
    J Mol Histol; 2005 May; 36(4):289-300. PubMed ID: 16200462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
    Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
    J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor-1 (IGF-1) protects NOD mice from insulitis and diabetes.
    Bergerot I; Fabien N; Maguer V; Thivolet C
    Clin Exp Immunol; 1995 Nov; 102(2):335-40. PubMed ID: 7586687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
    Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE
    J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fas and Fas ligand immunoexpression in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
    Reddy S; Ross JM
    Ann N Y Acad Sci; 2003 Nov; 1005():166-9. PubMed ID: 14679052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel function of islet-derived CD8+T cells in initiating and developing autoimmune insulin-dependent diabetes mellitus in non-obese diabetic (NOD) mice.
    Amano K; Yokono K; Hasegawa Y; Taki T; Tominaga Y; Yoneda R; Nagata M; Kasuga M
    Diabetes Res Clin Pract; 1995 Jun; 28(3):161-72. PubMed ID: 8529494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice.
    Wong FS; Visintin I; Wen L; Granata J; Flavell R; Janeway CA
    J Exp Med; 1998 Jun; 187(12):1985-93. PubMed ID: 9625758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
    Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG
    J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
    Hussain S; Delovitch TL
    J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
    Chosich N; Harrison LC
    Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice.
    Rohane PW; Shimada A; Kim DT; Edwards CT; Charlton B; Shultz LD; Fathman CG
    Diabetes; 1995 May; 44(5):550-4. PubMed ID: 7729614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.
    Augstein P; Dunger A; Heinke P; Wachlin G; Berg S; Hehmke B; Salzsieder E
    Biochem Biophys Res Commun; 2003 May; 304(2):378-84. PubMed ID: 12711326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.